<VariationArchive VariationID="10970" VariationName="NM_000475.5(NR0B1):c.501del (p.Gly169fs)" VariationType="Deletion" Accession="VCV000010970" Version="5" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-05-12" DateCreated="2016-08-22" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="26009" VariationID="10970">
      <GeneList>
        <Gene Symbol="NR0B1" FullName="nuclear receptor subfamily 0 group B member 1" GeneID="190" HGNC_ID="HGNC:7960" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xp21.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="30304206" stop="30309390" display_start="30304206" display_stop="30309390" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="30322538" stop="30327494" display_start="30322538" display_stop="30327494" Strand="-" />
          </Location>
          <OMIM>300473</OMIM>
          <Haploinsufficiency last_evaluated="2020-05-05" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=NR0B1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-05-05" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=NR0B1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000475.5(NR0B1):c.501del (p.Gly169fs)</Name>
      <CanonicalSPDI>NC_000023.11:30308862:T:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xp21.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="30308863" stop="30308863" display_start="30308863" display_stop="30308863" variantLength="1" positionVCF="30308862" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="30326980" stop="30326980" display_start="30326980" display_stop="30326980" variantLength="1" positionVCF="30326979" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>G169fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.30326980del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.30326980del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.30308863del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.30308863del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009814.1" sequenceAccession="NG_009814" sequenceVersion="1" change="g.5516del">
            <Expression>NG_009814.1:g.5516del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000475.5" sequenceAccession="NM_000475" sequenceVersion="5" change="c.501del" MANESelect="true">
            <Expression>NM_000475.5:c.501del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000466.2" sequenceAccession="NP_000466" sequenceVersion="2" change="p.Gly169fs">
            <Expression>NP_000466.2:p.Gly169fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_858" sequenceAccession="LRG_858">
            <Expression>LRG_858:g.5516del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_858t1" sequenceAccession="LRG_858t1">
            <Expression>LRG_858t1:c.501del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_858p1" sequenceAccession="LRG_858p1" change="p.Gly169fs">
            <Expression>LRG_858p1:p.Gly169fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="300473.0022" DB="OMIM" />
        <XRef Type="rs" ID="1569268976" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="ClinGen" Type="public">ClinGen staff contributed the HGVS expression for this variant.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000475.5(NR0B1):c.501del (p.Gly169fs) AND Congenital adrenal hypoplasia, X-linked" Accession="RCV000011717" Version="6">
        <ClassifiedConditionList TraitSetID="3046">
          <ClassifiedCondition DB="MedGen" ID="C0342482">Congenital adrenal hypoplasia, X-linked</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1999-12-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000475.5(NR0B1):c.501del (p.Gly169fs) AND multiple conditions" Accession="RCV003764555" Version="1">
        <ClassifiedConditionList TraitSetID="10091">
          <ClassifiedCondition DB="MedGen" ID="C1848296">46,XY sex reversal 2</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0342482">Congenital adrenal hypoplasia, X-linked</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-01-04" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000475.5(NR0B1):c.501del (p.Gly169fs) AND NR0B1-related disorder" Accession="RCV002280091" Version="3">
        <ClassifiedConditionList TraitSetID="79407">
          <ClassifiedCondition>NR0B1-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-06-29" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-01-04" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2016-08-22" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10599709</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">11748852</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15841486</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">7990958</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9529340</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3046" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="87" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Isolated X-Linked Adrenal Hypoplasia Congenita</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Congenital adrenal hypoplasia, X-linked</ElementValue>
                <XRef ID="Congenital+adrenal+hypoplasia%2C+X-linked/7542" DB="Genetic Alliance" />
                <XRef ID="237764004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Adrenal hypoplasia, congenital</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">X-linked AHC</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">ADRENAL HYPOPLASIA, CONGENITAL, WITH HYPOGONADOTROPIC HYPOGONADISM</ElementValue>
                <XRef Type="MIM" ID="300200" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">X-AHC</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">AHC</ElementValue>
                <XRef Type="MIM" ID="300200" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">AHCH</ElementValue>
                <XRef Type="MIM" ID="300200" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000520059" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000576178" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">NR0B1-related adrenal hypoplasia congenita includes both X-linked adrenal hypoplasia congenita (X-linked AHC) and Xp21 deletion (previously called complex glycerol kinase deficiency). X-linked AHC is characterized by primary adrenal insufficiency and/or hypogonadotropic hypogonadism (HH). Adrenal insufficiency is acute infantile onset (average age 3 weeks) in approximately 60% of affected males and childhood onset (ages 1-9 years) in approximately 40%. HH typically manifests in a male with adrenal insufficiency as delayed puberty (i.e., onset age &gt;14 years) and less commonly as arrested puberty at about Tanner Stage 3. Rarely, X-linked AHC manifests initially in early adulthood as delayed-onset adrenal insufficiency, partial HH, and/or infertility. Heterozygous females very occasionally have manifestations of adrenal insufficiency or hypogonadotropic hypogonadism. Xp21 deletion includes deletion of NR0B1 (causing X-linked AHC) and GK (causing glycerol kinase deficiency), and in some cases deletion of DMD (causing Duchenne muscular dystrophy). Developmental delay has been reported in males with Xp21 deletion when the deletion extends proximally to include DMD or when larger deletions extend distally to include IL1RAPL1 and DMD.</Attribute>
                <XRef ID="NBK1431" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="555" />
                <XRef ID="555" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301604</ID>
                <ID Source="BookShelf">NBK1431</ID>
              </Citation>
              <XRef ID="95702" DB="Orphanet" />
              <XRef ID="C0342482" DB="MedGen" />
              <XRef ID="MONDO:0010264" DB="MONDO" />
              <XRef Type="MIM" ID="300200" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="79407" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="65759" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">NR0B1-related disorder</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="10091" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="87" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Isolated X-Linked Adrenal Hypoplasia Congenita</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Congenital adrenal hypoplasia, X-linked</ElementValue>
                <XRef ID="Congenital+adrenal+hypoplasia%2C+X-linked/7542" DB="Genetic Alliance" />
                <XRef ID="237764004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Adrenal hypoplasia, congenital</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">X-linked AHC</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">ADRENAL HYPOPLASIA, CONGENITAL, WITH HYPOGONADOTROPIC HYPOGONADISM</ElementValue>
                <XRef Type="MIM" ID="300200" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">X-AHC</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">AHC</ElementValue>
                <XRef Type="MIM" ID="300200" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">AHCH</ElementValue>
                <XRef Type="MIM" ID="300200" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000520059" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000576178" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">NR0B1-related adrenal hypoplasia congenita includes both X-linked adrenal hypoplasia congenita (X-linked AHC) and Xp21 deletion (previously called complex glycerol kinase deficiency). X-linked AHC is characterized by primary adrenal insufficiency and/or hypogonadotropic hypogonadism (HH). Adrenal insufficiency is acute infantile onset (average age 3 weeks) in approximately 60% of affected males and childhood onset (ages 1-9 years) in approximately 40%. HH typically manifests in a male with adrenal insufficiency as delayed puberty (i.e., onset age &gt;14 years) and less commonly as arrested puberty at about Tanner Stage 3. Rarely, X-linked AHC manifests initially in early adulthood as delayed-onset adrenal insufficiency, partial HH, and/or infertility. Heterozygous females very occasionally have manifestations of adrenal insufficiency or hypogonadotropic hypogonadism. Xp21 deletion includes deletion of NR0B1 (causing X-linked AHC) and GK (causing glycerol kinase deficiency), and in some cases deletion of DMD (causing Duchenne muscular dystrophy). Developmental delay has been reported in males with Xp21 deletion when the deletion extends proximally to include DMD or when larger deletions extend distally to include IL1RAPL1 and DMD.</Attribute>
                <XRef ID="NBK1431" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="555" />
                <XRef ID="555" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301604</ID>
                <ID Source="BookShelf">NBK1431</ID>
              </Citation>
              <XRef ID="95702" DB="Orphanet" />
              <XRef ID="C0342482" DB="MedGen" />
              <XRef ID="MONDO:0010264" DB="MONDO" />
              <XRef Type="MIM" ID="300200" DB="OMIM" />
            </Trait>
            <Trait ID="1986" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">NR0B1-Related 46,XY CGD</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">NR0B1-related 46,XY complete gonadal dysgenesis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">46XY sex reversal 2, dosage-sensitive</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">46,XY sex reversal 2</ElementValue>
                <XRef ID="MONDO:0010226" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dosage-sensitive sex reversal</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">46,XY SEX REVERSAL, DAX1-RELATED</ElementValue>
                <XRef Type="MIM" ID="300018" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">SRXY2</ElementValue>
                <XRef Type="MIM" ID="300018" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">DSS</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9159" />
                <XRef ID="9159" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="general" Abbrev="LWPES/ESPE, 2006">
                <ID Source="PubMed">18947601</ID>
              </Citation>
              <XRef ID="C1848296" DB="MedGen" />
              <XRef ID="MONDO:0010226" DB="MONDO" />
              <XRef Type="MIM" ID="300018" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="31949" SubmissionDate="2016-08-10" DateLastUpdated="2016-08-22" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="300473.0022_ADRENAL HYPOPLASIA, CONGENITAL" title="NR0B1, 1-BP DEL, 501A_ADRENAL HYPOPLASIA, CONGENITAL" />
        <ClinVarAccession Accession="SCV000031949" DateUpdated="2016-08-22" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1999-12-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Seminara et al. (1999) studied an extended kindred with adrenal hypoplasia congenita with hypogonadotropic hypogonadism (300200) in which 2 males (the proband and his nephew) were affected with a nucleotide deletion (501delA) in the DAX1 gene. The proband's mother, sister, and niece were heterozygous for this frameshift mutation. At age 27 years, after 7 years of low dose hCG therapy, the proband underwent a testicular biopsy revealing rare spermatogonia and Leydig cell hyperplasia. Despite steadily progressive doses of hCG and Pergonal administered over a 3-year period, the proband remained azoospermic. The proband's mother, sister (obligate carrier), and niece all had a history of delayed puberty, with menarche occurring at ages 17-18 years. The authors concluded that (1) affected males with AHC/HHG may have an intrinsic defect in spermatogenesis that is not responsive to gonadotropin therapy; (2) female carriers of DAX1 mutations may express the phenotype of delayed puberty; and (3) although affected individuals display minimal responses to pulsatile gonadotropin-releasing hormone (152760), as observed in other AHC kindreds, subtle differences in gonadotropin patterns may nevertheless exist between affected individuals within a kindred.</Attribute>
              <Citation>
                <ID Source="PubMed">10599709</ID>
              </Citation>
              <XRef DB="OMIM" ID="300200" Type="MIM" />
              <XRef DB="OMIM" ID="152760" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NR0B1" />
          </GeneList>
          <Name>NR0B1, 1-BP DEL, 501A</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 501A</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="300473.0022" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">ADRENAL HYPOPLASIA, CONGENITAL</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8526266" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2024-02-28">
        <ClinVarSubmissionID localKey="4967095|MedGen:C0342482;C1848296" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004571459" DateUpdated="2024-02-28" DateCreated="2024-02-28" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">7990958</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15841486</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9529340</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11748852</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Gly169Alafs*95) in the NR0B1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NR0B1 are known to be pathogenic (PMID: 7990958, 15841486). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with clinical features of congenital adrenal hypoplasia (PMID: 9529340, 11748852). ClinVar contains an entry for this variant (Variation ID: 10970). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NR0B1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.30326980del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0342482" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1848296" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14224806</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5022228" SubmissionDate="2022-07-12" DateLastUpdated="2022-09-03" DateCreated="2022-09-03">
        <ClinVarSubmissionID localKey="53614653|NR0B1-related disorder" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002568252" DateUpdated="2022-09-03" DateCreated="2022-09-03" Type="SCV" Version="1" SubmitterName="Greenwood Genetic Center Diagnostic Laboratories, Greenwood Genetic Center" OrgID="1019" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-06-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>PVS1 PM2 PS4_Moderate</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NR0B1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000475.5:c.501del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">NR0B1-related disorder</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11782039</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="8526266" TraitType="Disease" MappingType="XRef" MappingValue="C0342482" MappingRef="MedGen">
        <MedGen CUI="C0342482" Name="Congenital adrenal hypoplasia, X-linked" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="31949" TraitType="Disease" MappingType="Name" MappingValue="ADRENAL HYPOPLASIA, CONGENITAL" MappingRef="Preferred">
        <MedGen CUI="C0342482" Name="Congenital adrenal hypoplasia, X-linked" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8526266" TraitType="Disease" MappingType="XRef" MappingValue="C1848296" MappingRef="MedGen">
        <MedGen CUI="C1848296" Name="46,XY sex reversal 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5022228" TraitType="Disease" MappingType="Name" MappingValue="NR0B1-related disorder" MappingRef="Preferred">
        <MedGen CUI="None" Name="NR0B1-related disorder" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

